TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2015

Immunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged ≥2 years: an open-label study.

Catherine Cordonnier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.